Merck reports additional positive data for Keytruda in NSCLC

Merck’s Keytruda shows improvements in non-small cell lung cancer patients. Credit: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.



  • Merck reports additional positive data for Keytruda in NSCLC